Detalles de la búsqueda
1.
Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
J Virol
; 89(15): 7813-28, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25995259
2.
The selection of low envelope glycoprotein reactivity to soluble CD4 and cold during simian-human immunodeficiency virus infection of rhesus macaques.
J Virol
; 88(1): 21-40, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24131720
3.
Gene deletions in Mycobacterium bovis BCG stimulate increased CD8+ T cell responses.
Infect Immun
; 82(12): 5317-26, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25287928
4.
Efficiency of cell-free and cell-associated virus in mucosal transmission of human immunodeficiency virus type 1 and simian immunodeficiency virus.
J Virol
; 87(24): 13589-97, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24109227
5.
Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease.
Blood
; 115(15): 3070-8, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20147699
6.
Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses.
J Virol
; 83(11): 5505-13, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19297477
7.
The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.
J Immunol
; 181(8): 5510-21, 2008 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18832708
8.
Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagm.
J Virol
; 82(23): 11577-88, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18829748
9.
Characterization of new anti-IL-6 antibodies revealed high potency candidates for intracellular cytokine detection and specific targeting of IL-6 receptor binding sites.
Eur Cytokine Netw
; 29(2): 59-72, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30148452
10.
Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.
Vaccine
; 33(42): 5715-5722, 2015 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26192357
11.
Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques.
Clin Vaccine Immunol
; 21(10): 1385-95, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25080550
12.
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.
PLoS One
; 9(9): e108383, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25255287
13.
Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates.
Curr Opin HIV AIDS
; 8(4): 273-9, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23615117
14.
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors.
Vaccine
; 27(42): 5837-45, 2009 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19660588
15.
No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys.
J Virol
; 81(22): 12368-74, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17686853
16.
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.
J Virol
; 81(12): 6594-604, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17428852
17.
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
J Virol
; 81(7): 3414-27, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17229693
18.
A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates.
J Virol
; 79(14): 8828-34, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15994776
19.
Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.
J Virol
; 77(19): 10348-56, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12970419
20.
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
J Immunol
; 172(10): 6290-7, 2004 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15128818